Evaluation of 9 rapid diagnostic tests for screening HIV infection, in Lome, Togo

被引：9

作者：

Dagnra, A. Y. ^{[1
]}

Dossim, S. ^{[1
]}

Salou, M. ^{[1
]}

Nyasenu, T. ^{[1
]}

Ali-Edje, K. ^{[1
]}

Ouro-Medeli, A. ^{[1
]}

Doufan, M. ^{[1
]}

Ehlan, A. ^{[1
]}

Prince-David, M. ^{[1
]}

机构：

[1] CHU Sylvanus Olympio, Ctr Natl Reference Tests VIH IST PNLS, Lome 8742 08, Togo

来源：

MEDECINE ET MALADIES INFECTIEUSES | 2014年 / 44卷 / 11-12期

关键词：

Rapid diagnostic test; HIV; Screening;

D O I：

10.1016/j.medmal.2014.10.007

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Purpose. HIV rapid diagnostic tests (RDT) could be greatly contributive for a universal access to HIV diagnosis. However, according to the WHO, these tests need to be assessed before they can be used in routine. Method and results. We assessed 9 RDT in routine clinical use between 2009 and 2013. The sensitivity and specificity observed for 7 tests were >= 99% and >= 98%, respectively: FIRST RESPONSE HIV1-2-O PMC Medical, India, GENIE Fast HIV 1,2 and GENIE(TM) III HIV(1/2)Bio-Rad, France, HIV TRI-DOT + Ag; J. Mitra, INDIA; SD BIOLINE HIV1/2 3.0 and SD BIOLINE HIV/SYPHILIS DUO Standard Diagnostic, Korea; and VIKIA HIV1/2; BioMerieux, France. Two tests had performances inferior to WHO recommendations: INSTI HIV1/2 Biolytical Canada; sensitivity = 97.8% and HEXAGON HIV HUMAN GmbH Germany; specificity = 94.8%. Conclusion. Seven of 9 RDT had excellent performances. Nevertheless, they can be used only after training staff, and taking into account national algorithm for their safe use. (C) 2014 Elsevier Masson SAS. All rights reserved.

引用

页码：525 / 529

页数：5

共 12 条

[1] Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions [J].

Apetrei, C ;

LoussertAjaka, I ;

Descamps, D ;

Damond, F ;

Saragosti, S ;

BrunVezinet, F ;

Simon, F .

AIDS, 1996, 10 (14) :F57-F60

[2] Feasibility and success of HIV point-of-care testing in an emergency department in an urban Canadian setting [J].

Becker, Marissa L. ;

Thompson, Laura H. ;

Pindera, Carla ;

Bridger, Natalie ;

Lopez, Carmen ;

Keynan, Yoav ;

Bullard, Jared ;

Van Caseele, Paul ;

Kasper, Ken .

CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2013, 24 (01) :27-31

[3]

Cook Darrel, 2010, Open AIDS J, V4, P176, DOI 10.2174/1874613601004010176

[4]

Dagnra A Y, 2002, Med Trop (Mars), V62, P507

[5] Unfinished business - Expanding HIV testing in developing countries [J].

De Cock, KM ;

Bunnell, R ;

Mermin, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (05) :440-442

[6] AIDS - Diversity considerations in HIV-1 vaccine selection [J].

Gaschen, B ;

Taylor, J ;

Yusim, K ;

Foley, B ;

Gao, F ;

Lang, D ;

Novitsky, V ;

Haynes, B ;

Hahn, BH ;

Bhattacharya, T ;

Korber, B .

SCIENCE, 2002, 296 (5577) :2354-2360

[7] HIV-1/HIV-2 SERONEGATIVITY IN HIV-1 SUBTYPE-O INFECTED PATIENTS [J].

LOUSSERTAJAKA, I ;

BRUNVEZINET, F ;

SIMON, F ;

LY, TD ;

CHAIX, ML ;

SARAGOSTI, S ;

COUROUCE, AM ;

INGRAND, D .

LANCET, 1994, 343 (8910) :1393-1394

[8]

McKenna SL, 1997, AIDS, V11, pS103

[9] Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting [J].

Pavie, Juliette ;

Rachline, Anne ;

Loze, Benedicte ;

Niedbalski, Laurence ;

Delaugerre, Constance ;

Laforgerie, Eric ;

Plantier, Jean-Christophe ;

Rozenbaum, Willy ;

Chevret, Sylvie ;

Molina, Jean-Michel ;

Simon, Francois .

PLOS ONE, 2010, 5 (07)

[10] SENSITIVITY OF UNITED-STATES HIV ANTIBODY TESTS FOR DETECTION OF HIV-1 GROUP-O INFECTIONS [J].

SCHABLE, C ;

ZEKENG, L ;

PAU, CP ;

HU, D ;

KAPTUE, L ;

GURTLER, L ;

DONDERO, T ;

TSAGUE, JM ;

SCHOCHETMAN, G ;

JAFFE, H ;

GEORGE, JR .

LANCET, 1994, 344 (8933) :1333-1334

← 1 2 →